The University of Chicago Header Logo

Connection

David Barefield to Animals

Back to Details
This is a "connection" page, showing publications David Barefield has written about Animals.
David Barefield
Connection Strength
0.609
Animals
  1. Myosin-binding protein-H: Not just filler. J Gen Physiol. 2024 Dec 02; 156(12).
    View in: PubMed
    Score: 0.062
  2. Proteolytic degradation of atrial sarcomere proteins underlies contractile defects in atrial fibrillation. Am J Physiol Heart Circ Physiol. 2024 08 01; 327(2):H460-H472.
    View in: PubMed
    Score: 0.060
  3. Myosin-binding protein H-like regulates myosin-binding protein distribution and function in atrial cardiomyocytes. Proc Natl Acad Sci U S A. 2023 Dec 19; 120(51):e2314920120.
    View in: PubMed
    Score: 0.058
  4. Partial and complete loss of myosin binding protein H-like cause cardiac conduction defects. J Mol Cell Cardiol. 2022 08; 169:28-40.
    View in: PubMed
    Score: 0.052
  5. Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle. Sci Rep. 2021 08 05; 11(1):15865.
    View in: PubMed
    Score: 0.049
  6. Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury. J Mol Cell Cardiol. 2019 04; 129:236-246.
    View in: PubMed
    Score: 0.042
  7. Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy. Circulation. 2017 Oct 17; 136(16):1477-1491.
    View in: PubMed
    Score: 0.037
  8. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. J Mol Cell Cardiol. 2015 Feb; 79:234-43.
    View in: PubMed
    Score: 0.031
  9. Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2014 Mar; 306(6):H807-15.
    View in: PubMed
    Score: 0.029
  10. Phosphorylation and function of cardiac myosin binding protein-C in health and disease. J Mol Cell Cardiol. 2010 May; 48(5):866-75.
    View in: PubMed
    Score: 0.022
  11. Sex and Gene Influence Arrhythmia Susceptibility in Murine Models of Calmodulinopathy. Circ Arrhythm Electrophysiol. 2023 09; 16(9):e010891.
    View in: PubMed
    Score: 0.014
  12. Intermittent glucocorticoid treatment enhances skeletal muscle performance through sexually dimorphic mechanisms. J Clin Invest. 2022 03 15; 132(6).
    View in: PubMed
    Score: 0.013
  13. Altered C10 domain in cardiac myosin binding protein-C results in hypertrophic cardiomyopathy. Cardiovasc Res. 2019 12 01; 115(14):1986-1997.
    View in: PubMed
    Score: 0.011
  14. A gene-edited mouse model of limb-girdle muscular dystrophy 2C for testing exon skipping. Dis Model Mech. 2019 11 04; 13(2).
    View in: PubMed
    Score: 0.011
  15. Recombinant annexin A6 promotes membrane repair and protects against muscle injury. J Clin Invest. 2019 11 01; 129(11):4657-4670.
    View in: PubMed
    Score: 0.011
  16. The naked mole-rat exhibits an unusual cardiac myofilament protein profile providing new insights into heart function of this naturally subterranean rodent. Pflugers Arch. 2017 Dec; 469(12):1603-1613.
    View in: PubMed
    Score: 0.009
  17. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J Clin Invest. 2017 Jun 01; 127(6):2418-2432.
    View in: PubMed
    Score: 0.009
  18. An actin-dependent annexin complex mediates plasma membrane repair in muscle. J Cell Biol. 2016 06 20; 213(6):705-18.
    View in: PubMed
    Score: 0.009
  19. Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption. Am J Pathol. 2016 06; 186(6):1610-22.
    View in: PubMed
    Score: 0.009
  20. Alterations in Multi-Scale Cardiac Architecture in Association With Phosphorylation of Myosin Binding Protein-C. J Am Heart Assoc. 2016 Mar 15; 5(3):e002836.
    View in: PubMed
    Score: 0.009
  21. Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping. J Clin Invest. 2015 Nov 02; 125(11):4186-95.
    View in: PubMed
    Score: 0.008
  22. Oxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation. Oxid Med Cell Longev. 2015; 2015:424751.
    View in: PubMed
    Score: 0.008
  23. The genetic landscape of cardiomyopathy and its role in heart failure. Cell Metab. 2015 Feb 03; 21(2):174-182.
    View in: PubMed
    Score: 0.008
  24. Sham surgery and inter-individual heterogeneity are major determinants of monocyte subset kinetics in a mouse model of myocardial infarction. PLoS One. 2014; 9(6):e98456.
    View in: PubMed
    Score: 0.008
  25. Phosphorylation of cMyBP-C affects contractile mechanisms in a site-specific manner. Biophys J. 2014 Mar 04; 106(5):1112-22.
    View in: PubMed
    Score: 0.007
  26. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-?B. Circulation. 2012 Jul 24; 126(4):418-29.
    View in: PubMed
    Score: 0.007
  27. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol. 2012 Jan; 52(1):154-64.
    View in: PubMed
    Score: 0.006
  28. A critical function for Ser-282 in cardiac Myosin binding protein-C phosphorylation and cardiac function. Circ Res. 2011 Jul 08; 109(2):141-50.
    View in: PubMed
    Score: 0.006
  29. Peritoneal dialysis solutions reverse the hemodynamic effects of nitric oxide synthesis inhibitors. Kidney Int. 1995 Dec; 48(6):1986-93.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.